These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12727158)

  • 1. Is prophylaxis the best use of the ICD? Response to the letter to the editor (Sharma et al.).
    Farré J; Nisam S
    Eur Heart J; 2003 May; 24(9):880-1. PubMed ID: 12727158
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination ICD and drug treatments-best options.
    Dorian P
    Resuscitation; 2000 Aug; 45(3):S3-6. PubMed ID: 10959027
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 5. A better control for ICD patients?
    Sharma S; Bhambi B; Ishimori T
    Eur Heart J; 2002 Dec; 23(24):1972. PubMed ID: 12473260
    [No Abstract]   [Full Text] [Related]  

  • 6. Do MADIT results apply only to "MADIT patients"? Multicenter Automatic Defibrillator Implantation Trial.
    Nisam S
    Am J Cardiol; 1997 Mar; 79(6A):27-30. PubMed ID: 9080863
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AVID necessity.
    Epstein AE
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1773-5. PubMed ID: 7692406
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiodarone for the Prevention of Sudden Cardiac Death.
    Saguil A
    Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction.
    Mannino MM; Mehta D; Langan NM; Gomes JA
    Am Heart J; 1996 Jun; 131(6):1251-9. PubMed ID: 8644621
    [No Abstract]   [Full Text] [Related]  

  • 13. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question?
    Josephson M; Nisam S
    Am J Cardiol; 1996 Apr; 77(10):859-63. PubMed ID: 8623740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized clinical trials: how long should they last?
    Wellens HJ
    Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of ventricular arrhythmias in heart failure: drugs or devices.
    Gambhir DS
    Indian Heart J; 1998; 50(5):507-10. PubMed ID: 10052273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.